<DOC>
	<DOCNO>NCT01095276</DOCNO>
	<brief_summary>The investigator hypothesize dornase alpha , administer twice day ( BID ) in-line nebulizer , would improve oxygenation , compliance , time extubation adult patient receive mechanical ventilation .</brief_summary>
	<brief_title>Impact Nebulized Dornase Alpha Mechanically Ventilated Patients</brief_title>
	<detailed_description>Background : Lobar segmental collapse lung mechanically ventilate patient relatively common occurrence Intensive Care Unit . Available treatment either labor time intensive highly effective . Methods : We conduct randomize , placebo-controlled , double-blind pilot study determine whether nebulized recombinant human dornase alpha ( Pulmozyme , Genentech ) improve radiologic clinical outcome ventilate patient lobar atelectasis . Outcomes interest chest radiograph score , oxygenation , lung compliance , rate extubation first 5 day . The group consist 14 intervention patient 16 control patient . They similar respect basic demographic , age , gender , use therapeutic modality relate lung function . Baseline average chest x-ray score , Pa02/FI02 ratio , static compliance significantly different . Analysis limit first 5 day . Results : There significant improvement oxygenation intervention group day 5 ( p=0.03 ) . There significant difference chest radiograph score , compliance , rate extubation . Two patient die intervention group , whereas none die control group ( NS ) . Conclusions : These pilot data suggest inhaled dornase alpha appear safe associate improved oxygenation 5 day initiation therapy mechanically ventilate patient compare placebo . Larger study need confirm finding determine intervention decrease ICU morbidity mortality .</detailed_description>
	<mesh_term>Pulmonary Atelectasis</mesh_term>
	<criteria>current ventilator use onset lobar whole lung collapse previous 12 hour age great 18 quadriplegia debilitate neuromuscular condition chronic ventilator dependence pneumothorax frank hemoptysis elevate intracranial pressure intracranial bleed pregnancy active nursing concurrent use investigational drug history allergy PulmozymeÂ® , Chinese Hamster Ovaryderived biologics , component active placebo formulation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Mechanical Ventilation</keyword>
	<keyword>Extubation</keyword>
	<keyword>dornase alpha</keyword>
	<keyword>oxygenation</keyword>
	<keyword>chest x ray</keyword>
</DOC>